Compare Japan Medical Dynamic Marketing, Inc. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a -17.16% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Operating profit has grown by an annual rate -17.16% of over the last 5 years
3
With a fall in Net Profit of -715.47%, the company declared Very Negative results in Jun 26
4
Risky -
Stock DNA
Pharmaceuticals & Biotechnology
JPY 24,914 Million (Small Cap)
30.00
NA
0.00%
0.10
1.10%
0.98
Revenue and Profits:
Net Sales:
5,326 Million
(Quarterly Results - Jun 2026)
Net Profit:
-423 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
64.15%
0%
64.15%
6 Months
75.05%
0%
75.05%
1 Year
59.93%
0%
59.93%
2 Years
15.69%
0%
15.69%
3 Years
3.2%
0%
3.2%
4 Years
-39.33%
0%
-39.33%
5 Years
-60.6%
0%
-60.6%
Japan Medical Dynamic Marketing, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.80%
EBIT Growth (5y)
-17.16%
EBIT to Interest (avg)
42.07
Debt to EBITDA (avg)
0.24
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.85
Tax Ratio
44.31%
Dividend Payout Ratio
170.21%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.49%
ROE (avg)
7.30%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
0.85
EV to EBIT
28.63
EV to EBITDA
9.86
EV to Capital Employed
0.86
EV to Sales
0.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.02%
ROE (Latest)
2.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
5,325.50
5,988.20
-11.07%
Operating Profit (PBDIT) excl Other Income
-98.00
473.70
-120.69%
Interest
59.90
55.70
7.54%
Exceptional Items
0.00
-0.10
100.00%
Consolidate Net Profit
-423.00
-24.10
-1,655.19%
Operating Profit Margin (Excl OI)
-98.80%
9.40%
-10.82%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is -11.07% vs -5.22% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is -1,655.19% vs -110.77% in Mar 2026
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
23,917.00
25,114.00
-4.77%
Operating Profit (PBDIT) excl Other Income
2,188.00
3,227.40
-32.21%
Interest
200.80
75.30
166.67%
Exceptional Items
-7.90
-1,778.40
99.56%
Consolidate Net Profit
274.90
-469.10
158.60%
Operating Profit Margin (Excl OI)
24.00%
62.00%
-3.80%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is -4.77% vs 8.35% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 158.60% vs -135.93% in Mar 2025
About Japan Medical Dynamic Marketing, Inc. 
Japan Medical Dynamic Marketing, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






